Skip to content
Institutional Investor seed early-stage Series A Series B Series C growth Est. 2000

Syngenta Group Ventures

Life-Sciences focused Early stage Corporate VC Firm investing in Europe & the US

📍 Basel, Switzerland

About This Fund

Syngenta Ventures is an Early stage corporate venture capital firm investing in Europe and the US. The firm focuses its investments in Life-Sciences sectors which include BioTech R&D, Biopharma, Diagnostics. Portfolio companies include Biognosys, GreenLight Biosciences, Illumitex, Metabolon.

Investment Focus

Sectors
agtech crop protection seeds biologicals precision agriculture robotics digital agriculture ag fintech
Stages
seed early-stage Series A Series B Series C growth
Check Size $10M-$50M
Geography
Global Brazil India

What They Look For

strategically relevant to agriculture innovation supporting Syngenta's core businesses (crop protection, seeds); technologies/business models with potential to transform agriculture/sustainability; global geography with emerging markets emphasis (e.g., India, Brazil); preference for platform/product/business model innovation; strong IP/teams without red flags like unproven tech or unrealistic projections

Preparing to pitch Syngenta Group Ventures?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →